Breaking News
Get 50% Off 0
👀 Ones to watch: The MOST undervalued stocks to buy right now
See Undervalued Stocks
Close

Janus Henderson Capital Funds Plc - Global Life Sciences Fund Class H2 Gbp (0P0000XRE3)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
58.870 +0.170    +0.29%
24/12 - Closed. Currency in GBP
Type:  Fund
Market:  United Kingdom
Issuer:  Janus Henderson Investors
ISIN:  IE00B8GQ0T69 
Asset Class:  Equity
  • Morningstar Rating:
  • Total Assets: 3.26B
Janus Capital Funds plc - Janus Global Life Scienc 58.870 +0.170 +0.29%

0P0000XRE3 Holdings

 
Comprehensive information about top holdings and Key Holding Information for the Janus Capital Funds plc - Janus Global Life Scienc (0P0000XRE3) fund. Our Janus Capital Funds plc - Janus Global Life Scienc portfolio information includes stock holdings, annual turnover, top 10 holdings, sector and asset allocation.

Asset Allocation

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Name  Net %  Long %  Short %
Cash 0.480 0.480 0.000
Stocks 98.620 98.620 0.000
Other 0.900 0.900 0.000

 Style Box

Value & Growth Measures

Ratios Value Category Average
P/E Ratio 18.652 20.585
Price to Book 4.829 4.183
Price to Sales 2.242 2.486
Price to Cash Flow 18.076 16.998
Dividend Yield 1.177 1.351
5 Years Earnings Growth 18.337 13.511

Sector Allocation

Name  Net % Category Average
Healthcare 100.000 94.945

Region Allocation

  • North America
  • Europe Developed
  • Asia
  • Africa & Middle East
  • Emerging Markets
  • Developed Markets

Top Holdings

Number of long holdings: 109

Number of short holdings: 109

Name ISIN Weight % Last Change %
  Eli Lilly US5324571083 8.62 783.17 -1.38%
  UnitedHealth US91324P1021 6.78 510.21 -0.18%
  Novo Nordisk B DK0062498333 4.46 635.9 +2.14%
  AbbVie US00287Y1091 3.79 178.01 -0.66%
  AstraZeneca GB0009895292 3.52 10,460.0 +0.23%
  Amgen US0311621009 3.39 262.65 -0.20%
  J&J US4781601046 2.79 145.10 -0.33%
  Sanofi FR0000120578 2.65 93.28 +1.67%
  Boston Scientific US1011371077 2.57 90.66 -0.86%
  Vertex US92532F1003 2.46 408.70 -0.47%

Top Equity Funds by Janus Henderson Investors

  Name Rating Total Assets YTD% 3Y% 10Y%
  S Horizon Global Technology Fund Ag 3.99B 30.47 10.79 18.24
  S Horizon Global Technology Fund 1g 3.99B 31.54 11.76 19.27
  S Horizon Global Technology Fund Hg 3.76B 25.39 11.13 19.12
  Opportunities Fund I Acc 1.96B -0.10 5.51 8.21
  Opportunities Fund I Inc 1.94B -0.12 5.51 8.20
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P0000XRE3 Comments

Write your thoughts about Janus Henderson Capital Funds Plc - Global Life Sciences Fund Class H2 Gbp
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email